Results 1 to 10 of about 391,281 (216)

Prevalence of Genomic Resistance to Macrolide in Mycoplasma Isolates among Children with Community Acquired Pneumonia [PDF]

Journal of Clinical and Diagnostic Research, 2022
Introduction: Mycoplasma pneumonia is traditionally susceptible to macrolides, tetracycline and fluroquinolones. Since, tetracycline and fluoroquinolone are used cautiously in children, macrolides remain the antibiotic of choice for treating ...
Sivasambo Kalpana, Shanmugam Selvakumar, Velmurugan Lakshmi , Prabhu Dhandapani, Prem Suruliraj   +4 more
doaj   +1 more source

Cavitatory necrotising pneumonia with extrapulmonary multi-systemic involvement — a rare presentation of macrolide-resistant Mycoplasma pneumoniae

The Egyptian Journal of Internal Medicine, 2023
Background Mycoplasma pneumoniae is one of the leading causes of community-acquired pneumonia. Due to its microbiological variation, clinical presentations of mycoplasma infections are atypical and diverse.
Namitha Mohan, Vishal Dnyaneshwar Sawant, Alpana Kondekar   +2 more
doaj   +1 more source

Peripheral blood microR-146a and microR-29c expression in children with Mycoplasma pneumoniae pneumonia and its clinical value

Italian Journal of Pediatrics, 2023
Background We investigated changes in microR-29c and microR-146a expression in the serum of children with Mycoplasma pneumoniae pneumonia, analysed their relationship with inflammatory factors and disease severity, and evaluated their diagnostic ...
Jingcai Wang, Chunyan Guo, Lixin Yang, Peng Sun, Xiaoqing Jing   +4 more
doaj   +1 more source

A fulminant pneumonia due to Mycoplasma pneumoniae – Case report and literature review

IDCases, 2022
Fulminant pneumonia due to Mycoplasma pneumoniae [MP] is quite rare even though there is a high prevalence of Mycoplasma species infection in the general population.We report a case of an atypical pneumonia with Acute Respiratory Distress Syndrome (ARDS)
Athira Unni, MD, P.K. Hidayathulla, MD, K.P. Kavitha, MD, Mohammed Niyas Paloth, MD, Priyanka Raveendranadhan Nair, MD, Jayesh Kumar P, MD, Chandni Radhakrishnan, MD PhD   +6 more
doaj   +1 more source

Clinical characteristics and serum inflammatory markers of community‐acquired mycoplasma pneumonia in children

Clinical Respiratory Journal, 2023
To compare the demographic and clinical features, laboratory and imaging findings in mycoplasma pneumoniae pneumonia (MPP) children with non‐MPP (NMPP) children and general MPP (GMPP) children with refractory MPP (RMPP) children and analysis the ...
F. Fan, Jun Lv, Qianyuan Yang, Fei Jiang
semanticscholar   +1 more source

Immune response plays a role in Mycoplasma pneumoniae pneumonia

Frontiers in Immunology, 2023
Introduction Mycoplasma pneumoniae (MP) is a major pathogen of community-acquired pneumonia in children. However, the specific pathogenesis of the progression of Mycoplasma pneumoniae pneumonia (MPP) is unclear.
Yifan Zhu, Yingying Luo, Ling Li, Xinyi Jiang, Yi Du, Jing Wang, Huilin Li, Haiyan Gu, Daiying Li, Heng Tang, Hou-bing Qin, Chang-juan Xu, Y. Liu, Deyu Zhao, Yun Guo, Feng Liu   +15 more
semanticscholar   +1 more source

Clinical features and risk factors of plastic bronchitis caused by refractory Mycoplasma pneumoniae pneumonia in children: a practical nomogram prediction model

European Journal of Pediatrics, 2023
Early assessment of refractory Mycoplasma pneumoniae pneumonia (RMPP) with plastic bronchitis (PB) allows timely removal of casts using fiberoptic bronchoscopic manipulation, which relieves airway obstruction and limit sequelae development.
Han Zhang, Jingjing Yang, Wenqi Zhao, Jing-Xin Zhou, Shuangyu He, Y. Shang, Qi Cheng   +6 more
semanticscholar   +1 more source

Recognition of refractory Mycoplasma pneumoniae pneumonia among Myocoplasma pneumoniae pneumonia in hospitalized children: development and validation of a predictive nomogram model

BMC Pulmonary Medicine, 2023
Backgroud The current diagnostic criteria for refractory Mycoplasma pneumoniae pneumonia (RMPP) among Mycoplasma pneumoniae Pneumonia (MPP) are insufficient for early identification, and potentially delayed appropriate treatment.
Meng Li, Xiang Wei, Shan-Shan Zhang, Shan Li, Su-Hong Chen, S. Shi, Shao-Hong Zhou, Da-Quan Sun, Qian-ye Zhao, Yan Xu   +9 more
semanticscholar   +1 more source

Global research trends of Mycoplasma pneumoniae pneumonia in children: a bibliometric analysis

Frontiers in Pediatrics, 2023
Background Mycoplasma pneumoniae pneumonia (MPP), attributable to Mycoplasma pneumoniae (MP), represents a predominant form of community-acquired pneumonia in pediatric populations, thereby posing a significant threat to pediatric health.
Zheping Song, Guangyuan Jia, Guangzhi Luo, Chengen Han, Baoqing Zhang, Xiao Wang   +5 more
semanticscholar   +1 more source

Neutrophil-to-lymphocyte ratio as a predictor of poor outcomes of Mycoplasma pneumoniae pneumonia

Frontiers in Immunology, 2023
Introduction Mycoplasma pneumoniae pneumonia (MPP) may lead to various significant outcomes, such as necrotizing pneumonia(NP) and refractory MPP (RMPP).
Dan Li, Haiyan Gu, Lei Chen, Ruxi Wu, Yazhou Jiang, Xia Huang, Deyu Zhao, Feng Liu   +7 more
semanticscholar   +1 more source